Please select the option that best describes you:
How would you treat a patient with a refractory primary splenic marginal zone lymphoma with symptomatic splenomegaly (20 cm) and a mild pancytopenia?
Prior trials of systemic therapy including alkylating agents and rituximab have failed and the patient is medically inoperable with no history of Hepatitis C. If you offer RT, what dose and target would you recommend? How often would you check a CBC and would you stop/hold treatment if the patient had worsening of cytopenia during radiation treatment?
Answer from: Radiation Oncologist at Academic Institution
Radiation therapy is utilized in two primary settings to palliate symptoms of splenomegaly in patients with hematologic malignancies.First, extramedullary hematopoiesis within the spleen can lead to symptomatic splenomegaly in a variety of hematologic malignancies (e.g., myelofibrosis). In this sett...
Sign in or Register to read more